doi: 10.1016/0014-2999(76)90283-1.
Inhibition of naloxone-induced withdrawal in morphine dependent mice by 1-trans-delta9-tetrahydrocannabinol
- PMID: 944134
- DOI: 10.1016/0014-2999(76)90283-1
Item in Clipboard
Inhibition of naloxone-induced withdrawal in morphine dependent mice by 1-trans-delta9-tetrahydrocannabinol
Eur J Pharmacol.
1976 Mar.
Abstract
The effects of various doses of 1-trans-delta9-tetrahydrocannabinol (delta9-THC) on naloxone-induced withdrawal were studied in mice rendered dependent on morphine by the pellet implantation procedure. When administered i.p., 30 min prior to naloxone, delta9-THC, inhibited the naloxone-induced withdrawal jumping response. Two other signs of morphine withdrawal (defecation and rearing behavior) were also suppressed by deltapTHC. It is suggested that delta9-THC or some of its derivatives may have potential use in narcotic detoxification.
Similar articles
-
Effect of some cannabinoids on naloxone-precipitated abstinence in morphine-dependent mice.Psychopharmacology (Berl). 1976 Sep 29;49(3):267-70. doi: 10.1007/BF00426828. Psychopharmacology (Berl). 1976. PMID: 826944
-
Time course of the effects of naturally occurring cannabinoids on morphine abstinence syndrome.Pharmacol Biochem Behav. 1978 Jan;8(1):7-11. doi: 10.1016/0091-3057(78)90115-6. Pharmacol Biochem Behav. 1978. PMID: 564515
-
Correlation between the in vivo and an in vitro expression of opiate withdrawal precipitated by naloxone: their antagonism by l-(-)-delta9-tetrahydrocannabinol.J Pharmacol Exp Ther. 1976 Nov;199(2):375-84. J Pharmacol Exp Ther. 1976. PMID: 988178
-
Morphine-dependent rats: blockade of precipitated abstinence by tetrahydrocannabinol.Science. 1975 Feb 7;187(4175):443-5. doi: 10.1126/science.1167428. Science. 1975. PMID: 1167428
-
Endogenous cannabinoid, 2-arachidonoylglycerol, attenuates naloxone-precipitated withdrawal signs in morphine-dependent mice.Brain Res. 2001 Aug 3;909(1-2):121-6. doi: 10.1016/s0006-8993(01)02655-5. Brain Res. 2001. PMID: 11478928
Cited by
-
Effect of Pharmacological Modulation of the Endocannabinoid System on Opiate Withdrawal: A Review of the Preclinical Animal Literature.Front Pharmacol. 2016 Jun 28;7:187. doi: 10.3389/fphar.2016.00187. eCollection 2016. Front Pharmacol. 2016. PMID: 27445822 Free PMC article. Review.
-
Interaction between delta 9-tetrahydrocannabinol and morphine on the motor activity of mice.Psychopharmacology (Berl). 1979 May 25;63(2):169-72. doi: 10.1007/BF00429697. Psychopharmacology (Berl). 1979. PMID: 112635
-
Medicinal Cannabis and Central Nervous System Disorders.Front Pharmacol. 2022 Apr 21;13:881810. doi: 10.3389/fphar.2022.881810. eCollection 2022. Front Pharmacol. 2022. PMID: 35529444 Free PMC article. Review.
-
Oleoyl glycine: interference with the aversive effects of acute naloxone-precipitated MWD, but not morphine reward, in male Sprague-Dawley rats.Psychopharmacology (Berl). 2019 Sep;236(9):2623-2633. doi: 10.1007/s00213-019-05237-9. Epub 2019 Apr 16. Psychopharmacology (Berl). 2019. PMID: 30993360
-
CB1 antagonism: interference with affective properties of acute naloxone-precipitated morphine withdrawal in rats.Psychopharmacology (Berl). 2014 Nov;231(22):4291-300. doi: 10.1007/s00213-014-3575-5. Epub 2014 Apr 27. Psychopharmacology (Berl). 2014. PMID: 24770676 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
